4//SEC Filing
DelMar Pharmaceuticals, Inc. 4
Accession 0000905718-17-000668
$HURACIK 0001498382operating
Filed
Jul 10, 8:00 PM ET
Accepted
Jul 11, 9:41 PM ET
Size
7.8 KB
Accession
0000905718-17-000668
Insider Transaction Report
Form 4
Zarrabian Saiid
DirectorInterim CEO
Transactions
- Award
Options (Right to Buy)
2017-07-07+36,000→ 36,000 totalExercise: $2.11From: 2020-07-07Exp: 2027-07-07→ Common Stock (36,000 underlying) - Award
Performance Stock Units
2017-07-07+200,000→ 200,000 totalExp: 2022-07-07→ Common Stock (200,000 underlying)
Footnotes (2)
- [F1]12,000 options vest on June 30, 2018, and 3,000 options vest each three months thereafter starting September 30, 2018.
- [F2]Subject to stockholder approval of the Company's 2017 Omnibus Equity Incentive Plan at the Company's annual meeting, each performance stock unit represents the right to receive one share of common stock upon vesting of the unit based on targets related to the Company's financial performance.
Documents
Issuer
DelMar Pharmaceuticals, Inc.
CIK 0001498382
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001498382
Filing Metadata
- Form type
- 4
- Filed
- Jul 10, 8:00 PM ET
- Accepted
- Jul 11, 9:41 PM ET
- Size
- 7.8 KB